☆ 4.7 Article

The economic burden of individuals living with generalized myasthenia gravis and facing social determinants of health challenges

FRONTIERS IN PUBLIC HEALTH (2023)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

A real-world analysis of factors associated with high healthcare resource utilization and costs in patients with myasthenia gravis receiving second-line treatment

Angela Ting et al.

Summary: Despite current treatments, patients with myasthenia gravis (MG) still face unpredictable symptoms and significant economic burden, especially those initiating second-line therapy. Limited data on the healthcare costs of MG patients, especially those receiving second-line therapy, are available. This study analyzed claims data from the IBM (R) MarketScan (R) database to examine patient characteristics, healthcare resource utilization, and costs in this population. The findings suggest that disease characteristics, such as exacerbation and treatment history, can indicate future high costs.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2023)

Add to Collection

Article Health Care Sciences & Services

Development of a Long-Term Cross-Sectoral Case and Care Management Manual for Patients With Severe Multiple Sclerosis and Their Caregivers

Anne Mueller et al.

Summary: Care and case management is aimed at providing optimal care for patients and their caregivers. In the COCOS-MS study, a semistructured manual is being tested to facilitate a clear and systematic CCM process. The manual serves as a tool for long-term, cross-sectoral care for individuals with severe multiple sclerosis and their caregivers.

PROFESSIONAL CASE MANAGEMENT (2023)

Add to Collection

Article Public, Environmental & Occupational Health

Interventions to reduce cancer screening inequities: the perspective and role of patients, advocacy groups, and empowerment organizations

Afua Richardson-Parry et al.

Summary: This article aims to present the viewpoint of patients, survivors, advocates, and lay persons on interventions to increase cancer screening from a health inequity perspective. The study found that viewing screening as a continuum, individually tailored interventions, and targeting hard-to-reach populations are major considerations. It is also essential to involve patient advocacy groups and relevant lay persons in the creation and implementation of interventions.

INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH (2023)

Add to Collection

Article Clinical Neurology

Understanding the Symptom Burden and Impact of Myasthenia Gravis from the Patient's Perspective: A Qualitative Study

Kristi Jackson et al.

Summary: This study conducted one-on-one interviews with 28 gMG patients in the US to understand their experiences with symptoms, the most bothersome symptoms, and the impact on their daily lives, as well as their treatment goals. The results showed that the fluctuating and unpredictable nature of gMG symptoms have a substantial impact on patients' emotional, social, and economic well-being. Participants' treatment goals highlighted the importance of achieving symptom stability to resume a normal lifestyle quickly.

NEUROLOGY AND THERAPY (2023)

Add to Collection

Article Public, Environmental & Occupational Health

Impact of social determinants of health on individuals living with generalized myasthenia gravis and implications for patient support programs

Tom Hughes et al.

Summary: Social determinants of health (SDOH) have a significant impact on individuals diagnosed with rare, chronic diseases. This study found that individuals living with generalized myasthenia gravis (gMG) face financial and mental health concerns, with low awareness and utilization of available support services. Targeted approaches and collaborations with relevant organizations are needed to better support individuals with gMG experiencing SDOH barriers.

FRONTIERS IN PUBLIC HEALTH (2023)

Add to Collection

Article Multidisciplinary Sciences

Real world study on prevalence, treatment and economic burden of myasthenia gravis in Italy

Giovanni Antonini et al.

Summary: The purpose of this study was to investigate the epidemiology, management, and economic burden of myasthenia gravis in real clinical practice. The estimated prevalence of myasthenia gravis in Italy during 2018 was in the range of 13.5-29.3/100,000 people, with a large number of patients using pyridostigmine and corticosteroids for treatment. The total healthcare costs for myasthenia gravis were significantly higher than those of the general population, especially for patients with exacerbation.

HELIYON (2023)

Add to Collection

Review Public, Environmental & Occupational Health

Social Needs Resource Connections: A Systematic Review of Barriers, Facilitators, and Evaluation

Anna Louise Steeves-Reece et al.

Summary: This systematic mixed studies review examines how studies evaluate social needs resource connections and identifies patient- and caregiver-reported factors that may hinder or facilitate resource connections. The review found barriers to resource connections included inadequacy, irrelevancy, or restrictiveness of resources; inaccessibility; fears of stigma or discrimination; and factors related to staff training and resource information sharing. Facilitators included relevant referrals, support and simplicity embedded in interventions, and comprehensive and inclusive interventions.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2022)

Add to Collection

Article Clinical Neurology

Burden of disease in myasthenia gravis: taking the patient's perspective

Sophie Lehnerer et al.

Summary: Patients with myasthenia gravis (MG) have lower health-related quality of life (HRQoL) compared to the general population, with economic, social, and emotional aspects contributing to the burden of the disease. Factors associated with lower HRQoL in MG patients include female gender, older age, low income, lack of partner, limited daily activities, symptoms of depression, anxiety, fatigue, and perceived low social support.

JOURNAL OF NEUROLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Communication, Coordination, and Security for People with Multiple Sclerosis (COCOS-MS): a randomised phase II clinical trial protocol

Heidrun Golla et al.

Summary: In this explorative phase II clinical trial, the effects of care and case management (CCM) on the quality of life and treatment-related risk perception of multiple sclerosis (MS) patients will be evaluated. The study will assess CCM through regular data assessments and individual interviews and aim to develop a final design for a confirmative phase III trial.

BMJ OPEN (2022)

Add to Collection

Article Clinical Neurology

Real-World Healthcare Resource Utilization and Cost Burden Assessment for Adults With Generalized Myasthenia Gravis in the United States

Glenn Phillips et al.

Summary: This study investigated healthcare resource utilization and associated costs for adults with generalized myasthenia gravis (gMG) in the United States. The results showed that newly diagnosed patients had higher healthcare resource utilization and costs compared to previously diagnosed patients, and costs further increased for patients with exacerbation events. For patients who experienced crisis events, costs significantly increased during the 12 months before the event and further increased in the 12 months following the event. The high costs were largely attributed to the treatments received.

FRONTIERS IN NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis

Linda Harris et al.

Summary: This study found that conventional treatments for generalized myasthenia gravis (MG) are not adequately managing patients' symptoms, and patients with treatment-refractory MG are more likely to experience certain comorbidities. Future research should focus on the impact of newer targeted therapies on long-term clinical outcomes and comorbid conditions.

BMC NEUROLOGY (2022)

Add to Collection

Article Health Care Sciences & Services

The role of advocacy and empowerment in shaping service development for families raising children with developmental disabilities

Zsofia Szlamka et al.

Summary: This qualitative study explored stakeholder perceptions on the role of advocacy and empowerment in developing caregiver interventions for families of children with developmental disabilities globally. Three themes emerged: empowerment as independence and as a right; the role and practices of advocacy; and using evidence to drive advocacy.

HEALTH EXPECTATIONS (2022)

Add to Collection

Review Clinical Neurology

The humanistic burden of myasthenia gravis: A systematic literature review

Deborah Gelinas et al.

Summary: This systematic literature review aimed to explore the humanistic burden of myasthenia gravis (MG) on patients and caregivers in terms of psychological symptoms and health-related quality of life (HRQoL). The review found that patients with MG had worse HRQoL compared to the general population. Studies on psychological symptoms showed that more severe symptoms and longer hospitalization days were associated with worse depression and anxiety, while fatigue and sleep improved with disease remission and/or improvement.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2022)

Add to Collection

Editorial Material Clinical Neurology

Stroke Care Costs and Cost-Effectiveness to Inform Health Policy

Janet Prvu Bettger et al.

STROKE (2022)

Add to Collection

Article Medicine, General & Internal

Current Treatment of Myasthenia Gravis

Mohammed K. Alhaidar et al.

Summary: This review summarizes the current treatment options for myasthenia gravis (MG), including immunosuppressive and non-immunosuppressive treatments, as well as thymectomy and targeted immunomodulatory drugs.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Socio-Economic Burden of Myasthenia Gravis: A Cost-of-Illness Study in Bulgaria

Valentina Ignatova et al.

Summary: This study estimated the annual costs of MG patients in Bulgaria from a societal perspective and found that direct healthcare costs slightly outweighed indirect costs, with drug costs having the biggest impact. Severe generalized disease, disease crises, and recurrent infections were identified as significant cost drivers. The reliance on family members as informal caregivers among Bulgarian MG patients was common, likely due to the lack of access to appropriate social services. Further research and targeted health policies are needed to meet the needs of these patients.

FRONTIERS IN PUBLIC HEALTH (2022)

Add to Collection

Article Endocrinology & Metabolism

Underrepresented Voices: Impacts of Social Determinants of Health on Type 1 Diabetes Family Management in Single-Parent, Black Families

Jennifer F. Morone et al.

Summary: This qualitative study aimed to identify and explore the social determinants of health (SDOH) that impact the management of type 1 diabetes in Black, single-parent families. The study found that parents faced various SDOH-related issues, including lack of support systems, maintaining health, medication management, clinical team empathy, provider communication, and economic burden. These findings contribute to the development of culturally relevant interventions to address health equity and racial health disparities in type 1 diabetes.

CANADIAN JOURNAL OF DIABETES (2022)

Add to Collection

Review Immunology

Role of complement, anti-complement therapeutics, and other targeted immunotherapies in myasthenia gravis

Marinos C. Dalakas

Summary: This paper discusses target-specific immunotherapies that promise long-term remissions in the management of myasthenia gravis (MG), including anti-complement therapeutics and anti-FcRn and B cell monoclonal antibodies. These biologics offer effective targeted immunotherapies with good tolerance, promising to change the therapeutic algorithm in the chronic MG management.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Unfavorable social determinants of health are associated with higher burden of financial toxicity among patients with atherosclerotic cardiovascular disease in the US: findings from the National Health Interview Survey

Javier Valero-Elizondo et al.

Summary: This study found a strong association between the cumulative effect of social determinants of health and financial toxicity from healthcare, providing further evidence for policies and interventions to address this issue.

ARCHIVES OF PUBLIC HEALTH (2022)

Add to Collection

Review Health Care Sciences & Services

Cost-effectiveness of Case Management: A Systematic Review

Ann-Kathrin Klaehn et al.

Summary: This study reviewed 29 studies and found that case management methods show promise in supporting patients facing complex care situations. However, there is high variation among case management approaches, and further research is needed to determine the most cost-effective way to provide such care coordination.

AMERICAN JOURNAL OF MANAGED CARE (2022)

Add to Collection

Article Clinical Neurology

Social, professional and neuropsychiatric outcomes in patients with myasthenia gravis

Bruno Kusznir Vitturi et al.

Summary: Patients with MG experience social, professional, and mental disadvantages, with many facing unemployment or reduced income after diagnosis, only a small percentage receiving financial support and satisfactory social support, and a high prevalence of neuropsychiatric symptoms.

NEUROLOGICAL SCIENCES (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Research with youth of color in low-income communities: Strategies for recruiting and retaining participants

Tamar Mendelson et al.

Summary: Research with low-income urban youth of color requires strategies such as developing university-community partnerships, effective participant recruitment, and retention, while paying attention to youth characteristics like gender and ethnicity to minimize bias in study results. Lessons learned from a school-based trial emphasize the importance of maximizing scientific rigor, promoting positive research experiences, and providing concrete benefits to participants.

RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2021)

Add to Collection

Article Health Care Sciences & Services

The Cost of Implementing and Sustaining the COMprehensive Post-Acute Stroke Services Model

William S. Bayliss et al.

Summary: The study found that the costs of implementing COMPASS varied across hospitals. Hospitals with higher stroke patient volume and higher enrollment reported lower costs per patient. If the COMPASS model can prevent about 6 readmissions per year, it could potentially lower net costs.

MEDICAL CARE (2021)

Add to Collection

Article Clinical Neurology

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT) : a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Jr Jr Howard et al.

Summary: The study evaluated the safety and efficacy of efgartigimod in patients with generalised myasthenia gravis, showing that it was well tolerated and efficacious. The unique feature of individualized dosing based on clinical response in the study will provide further insights into clinical practice with longer term data from the ongoing open-label extension.

LANCET NEUROLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations

Laura Dresser et al.

Summary: Myasthenia gravis (MG) is an autoimmune neurological disorder characterized by defective transmission at the neuromuscular junction. The core clinical manifestation is fatigable muscle weakness, which may vary according to the type of autoantibody and whether a thymoma is present.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Urology & Nephrology

Living Well with Kidney Disease by Patient and Care-Partner Empowerment: Kidney Health for Everyone Everywhere

Kamyar Kalantar-Zadeh et al.

Summary: Living with chronic kidney disease can be challenging for patients and their care-partners, but empowering them can help minimize the burden. The focus on patient empowerment and life participation in kidney disease care is crucial for promoting well-being and quality of life.

NEPHRON (2021)

Add to Collection

Review Endocrinology & Metabolism

Social Determinants of Health and Diabetes: A Scientific Review

Felicia Hill-Briggs et al.

DIABETES CARE (2021)

Add to Collection

Article Clinical Neurology

A study of comorbidities in myasthenia gravis

Usha K. Misra et al.

ACTA NEUROLOGICA BELGICA (2020)

Add to Collection

Article Anesthesiology

Effect of Sugammadex on Postoperative Myasthenic Crisis in Myasthenia Gravis Patients: Propensity Score Analysis of a Japanese Nationwide Database

Hideyuki Mouri et al.

ANESTHESIA AND ANALGESIA (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Burden and impact of takotsubo syndrome in myasthenic crisis: A national inpatient perspective on the under-recognized but potentially fatal association

Rupak Desai et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)

Add to Collection

Review Public, Environmental & Occupational Health

Employment in Myasthenia Gravis: A Systematic Literature Review and Meta-Analysis

Erika Guastafierro et al.

NEUROEPIDEMIOLOGY (2020)

Add to Collection

Article Genetics & Heredity

Out-of-pocket expenses for myasthenia gravis patients in China: a study on patients insured by basic medical insurance in China, 2013-2015

Tao-yu Lin et al.

ORPHANET JOURNAL OF RARE DISEASES (2020)

Add to Collection

Review Economics

Economic Costs of Myasthenia Gravis: A Systematic Review

Eri Landfeldt et al.

PHARMACOECONOMICS (2020)

Add to Collection

Review Clinical Neurology

Progress in the therapy of myasthenia gravis: getting closer to effective targeted immunotherapies

Marinos C. Dalakas

CURRENT OPINION IN NEUROLOGY (2020)

Add to Collection

Article Health Care Sciences & Services

Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study

Jingshan Chen et al.

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2020)

Add to Collection

Review Medicine, General & Internal

A Review of Psychiatric Comorbidity in Myasthenia Gravis

Christina Law et al.

CUREUS JOURNAL OF MEDICAL SCIENCE (2020)

Add to Collection

Article Clinical Neurology

Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysis

Linda Harris et al.

MUSCLE & NERVE (2019)

Add to Collection

Article Clinical Neurology

Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment

Gary Cutter et al.

MUSCLE & NERVE (2019)

Add to Collection

Review Clinical Neurology

Understanding the burden of refractory myasthenia gravis

Christiane Schneider-Gold et al.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)

Add to Collection

Article Primary Health Care

Case Management in Primary Care for Frequent Users of Health Care Services: A Mixed Methods Study

Catherine Hudon et al.

ANNALS OF FAMILY MEDICINE (2018)

Add to Collection

Article Medicine, General & Internal

Association of a Care Coordination Model With Health Care Costs and Utilization The Johns Hopkins Community Health Partnership (J-CHiP)

Scott A. Berkowitz et al.

JAMA NETWORK OPEN (2018)

Add to Collection

Article Clinical Neurology

Direct and indirect cost of myasthenia gravis: A prospective study from a tertiary care teaching hospital in India

Kamlesh Kumar Sonkar et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2017)

Add to Collection

Article Clinical Neurology

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard et al.

LANCET NEUROLOGY (2017)

Add to Collection

Article Clinical Neurology

Inpatient cost analysis for treatment of myasthenia gravis

Jacklyn O. Omorodion et al.

MUSCLE & NERVE (2017)

Add to Collection

Article Medicine, General & Internal

Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study

Yuriko Nagane et al.

BMJ OPEN (2017)

Add to Collection

Article Clinical Neurology

COST-MINIMIZATION ANALYSIS COMPARING INTRAVENOUS IMMUNOGLOBULIN WITH PLASMA EXCHANGE IN THE MANAGEMENT OF PATIENTS WITH MYASTHENIA GRAVIS

Julio C. Furlan et al.

MUSCLE & NERVE (2016)

Add to Collection

Article Clinical Neurology

Labour market participation and sick leave among patients diagnosed with myasthenia gravis in Denmark 1997-2011: a Danish nationwide cohort study

Asger Frost et al.

BMC NEUROLOGY (2016)

Add to Collection

Article Clinical Neurology

Reducing Readmissions After Stroke With a Structured Nurse Practitioner/Registered Nurse Transitional Stroke Program

Christina Condon et al.

STROKE (2016)

Add to Collection

Article Clinical Neurology

Clinical features and impact of myasthenia gravis disease in Australian patients

Stefan Blum et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2015)

Add to Collection

Article Nursing

Outcomes of a Quality Improvement Project Implementing Stroke Discharge Advocacy to Reduce 30-Day Readmission Rates

Kristen M. Poston et al.

JOURNAL OF NURSING CARE QUALITY (2014)

Add to Collection

Article Clinical Neurology

Estimated cost of treating myasthenia gravis in an insured U.S. population

Jeffery T. Guptill et al.

MUSCLE & NERVE (2012)

Add to Collection

Article Clinical Neurology

COST ANALYSIS OF MYASTHENIA GRAVIS FROM A LARGE U.S. INSURANCE DATABASE

Jeffrey T. Guptill et al.

MUSCLE & NERVE (2011)

Add to Collection

Article Clinical Neurology

Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy

Karsten Schepelmann et al.

JOURNAL OF NEUROLOGY (2010)

Add to Collection

Article Public, Environmental & Occupational Health

Nationwide Population-Based Epidemiological Study of Myasthenia Gravis in Taiwan

Chien-Hsu Lai et al.

NEUROEPIDEMIOLOGY (2010)

Add to Collection

Article Health Care Sciences & Services

The Impact of a Proactive Chronic Care Management Program on Hospital Admission Rates in a German Health Insurance Society

Brent Hamar et al.

POPULATION HEALTH MANAGEMENT (2010)

Add to Collection

© Peeref 2019-2024. All rights reserved.